Zepbound is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist administered as a once-weekly subcutaneous injection
By decreasing glucagon release, these agonists support the body in maintaining more consistent blood sugar levels, which not only aids in weight loss but also provides overall metabolic benefits
If your Lexapro feels like it is not working as well as it used to, alcohol is one of the first things to look at before asking for a dose increase
How do I reconstitute Retatrutide for laboratory research
Medications like semaglutide (Ozempic, Wegovy) are modified to resist DPP-4 breakdown, maintaining high GLP-1 activity for days rather than minutes
Based on published clinical data, oral semaglutide 25 mg daily produces steady-state plasma exposures that approach but may not fully match injectable 2.4 mg weekly (Wegovy)